What's in Centre for Chronic Disease Control, India's pipeline?

Centre for Chronic Disease Control, India has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Centre for Chronic Disease Control, India's portfolio?

Top competitors by shared drug class: TSH Biopharm Corporation Limited.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/centre-for-chronic-disease-control-india.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Centre for Chronic Disease Control, India — Portfolio Competitive Intelligence Brief

Centre for Chronic Disease Control, India pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Amlodipine + Perindopril	Amlodipine + Perindopril	marketed	Calcium channel blocker + ACE inhibitor combination	L-type voltage-gated calcium channels; Angiotensin-converting enzyme (ACE)	Cardiovascular
Amlodipine + Indapamide	Amlodipine + Indapamide	marketed	Calcium channel blocker + Thiazide-like diuretic combination	L-type voltage-gated calcium channels (amlodipine); sodium-chloride cotransporter (indapamide)	Cardiovascular
Perindopril + Indapamide	Perindopril + Indapamide	marketed	ACE inhibitor + thiazide-like diuretic combination	Angiotensin-converting enzyme (ACE); sodium-chloride cotransporter	Cardiovascular

Therapeutic area mix

Cardiovascular · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

TSH Biopharm Corporation Limited · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Centre for Chronic Disease Control, India:

Cite this brief

Drug Landscape (2026). Centre for Chronic Disease Control, India — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/centre-for-chronic-disease-control-india. Accessed 2026-05-16.